ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: PP04

Improved Quality of Life with Patient Engagement in Research

Kelly English1 and Graham Macdonald2, 1Arthritis Patient Advisory Board, Arthritis Research Canada, Richmond, BC, Canada, 2Occupational Science and Occupational Therapy, University of British Columbia, Vancouver, BC, Canada

Meeting: 2018 ACR/ARHP Annual Meeting

Keywords: patient engagement, Patient participation, quality of life and rheumatoid arthritis (RA)

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Sunday, October 21, 2018

Title: 3S041 ACR/ARHP: Patient Perspectives Poster Session

Session Type: Patient Perspectives Poster Session

Session Time: 12:00PM-2:00PM

Background/Diagnosis: I am a woman, 60 years old who has lived with difficult-to-treat Rheumatoid Arthritis for 23 years. When first  diagnosed with RA, there were constant tests, doctor’s appointments, stress management classes, education classes, pain and illness to deal with as well as 2 young boys who needed their mother to be there to enjoy life with them.

My best was saved for my boys but could not do the everyday things we had done in the past. We had to sell our house as it was not disability-friendly and there were financial needs relating to my disease. It took a year to diagnose and I had trouble with every med that was given to me; there was little efficacy as well.

When biologics came into play, things were a little better for a couple of years, although I experienced constant infections.  Then a severe reaction to a TNF receptor left me with neuropathic damage to my right leg that was not able to be reversed. The result is permanent pain on that side. It has affected my balance, gait and concentration.

Treatment: I am a patient fully engaged in several research teams from the point of hearing about a research idea and guiding the direction of research, to lay summaries and dissemination, and every phase of research in between. My 5 years since joining the Arthritis Patient Advisory Board has seen participation in quality of life research projects testing activity monitors, health journals and medicine adherence focus groups. I hoped this would give me a way to improve my life and give me new ideas about my RA. The environment at Arthritis Research Canada is an amazing one. Everyone from the scientific director to the secretaries to the trainees understand my disease and are flexible as well as encouraging. Patient engagement on research is a given here – not an exception to the rule.

 

Maintenance: See table 1

Table 1

Research Study

Goals

Difference to Me

Health Ethics

 

Focus group on social media & ethics

Start to my journey. Made me realize how much of new technology I was not using. I.e.: fitness trackers, wellness apps

Answer 2

 

To help people with decision making around Biologics

Great teaching tool about decision making – helped with video and with testing product. – became aware of other’s concerns with meds.

-could also check to see some of the available meds before talking to my rd.

Health Journal

To test a health journal testing joint count, depression screening, reporting to rheumatologist.

Since using this I have been more aware of symptoms and have gone back to record my past meds and reactions/side effects.

Fitbit/Fitviz/ OPERA

 

Using a fitness tracker, combined with a physio consultation & now being tested as a complete program with Health Journal

This has been a game changer in my health.

-Aware of how many active minutes of exercise, how closely or how apart they are, activity every hour.

– invested in as I have been in the program throughout the testing/research period, from testing the product to critiquing the almost finished software changes.

Medicine Adherence focus group

 

Focus group on how people both remember to take and why they don’t take medications for RA

Despite reading about this; I had no idea that people had so many reasons not to take and fears around medication

-have been extra vigilant about my own meds especially compliant with vitamins

Framework for Patient Engagement in Research

To develop a framework for Patient Engagement in Research that will work not just in the Arthritis field but in any health field

-involved in from the beginning to dissemination. It has been true Patient Engagement in Research and is the project I am most proud to be in

-have co-presented the poster at ACR2017

-have assisted in developing the statements for the framework, wording of research paper, disseminated the information

– have seen the process from start to finish which has been most important

PRECISION: Preventing Complications from Inflammatory Skin, Joint and Bowel Conditions

 

Sit on the consumer core of the panel

 

-Through PRECISION I have expanded my medical vocabulary. This has enabled me to understand better the posters at ACR and at the Canadian Rheumatology conferences

– As part of the consumer core have heard of new discoveries as the team has researched them.

-alerted on health problems such as potential COPD in the future

-it has given me great hope as research by Dr. Diane Lacaille has shown that the lifespan of people with RA has actually improved over time. These are simply 2 discoveries out of many that have come out of this group

 

Quality of Life:

It has been a long journey getting to where I am now. Results of Being a Patient in Research are:

-a team member on research projects

– an improvement in my fitness level,

–  vitamin use is optimal

– self esteem is higher than ever

–  improved communication with my doctors by knowing medical terminology and treatments ahead of my appointments, and by having knowledge of new research findings to share with my rheumatologist and general practitioner from conferences and the research teams

–  very supportive community in Arthritis Research Canada’s Arthritis Patient Advisory Board

– attended ACR conferences and Canadian Rheumatology Conferences since I have been on the advisory board

– have a vested interest in the health research and pay very close attention to stretching my health knowledge and adherence. I know my quality of life has improved and my doctors acknowledge this.

– Depression has decreased.

My quality of life and the contributions I have made to others’ lives is a result of being a Patient Engaged in Research.

 

 


Disclosure: K. English, None; G. Macdonald, None.

To cite this abstract in AMA style:

English K, Macdonald G. Improved Quality of Life with Patient Engagement in Research [abstract]. Arthritis Rheumatol. 2018; 70 (suppl 9). https://acrabstracts.org/abstract/improved-quality-of-life-with-patient-engagement-in-research/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2018 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/improved-quality-of-life-with-patient-engagement-in-research/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology